// App-Quantinova.ai

: DRES-09. IN VIVO FUNCTIONAL GENOMICS IDENTIFIES DRIVERS OF CHEMORESISTANCE IN MEDULLOBLASTOMA

Researchers

Presenter

  • Ana Guerreiro Stücklin

Principal Investigators

  • Livia Garzia

  • Patryk Skowron

  • Pasqualino De Antonellis

  • Carolina Nor

  • Xiaochong Wu

  • Michael Taylor

Medical Centers

  • Department of Developmental & Stem Cell Biology and Division of Neurosurgery, Hospital for Sick Children, Toronto, ON, Canada

  • RI-MUHC, Cancer Research Program and Dept of Surgery, Faculty of Medicine, McGill University, Montreal, QC, Canada

  • Developmental & Stem Cell Biology, The Hospital for Sick Children, Toronto, ON, Canada

  • Department of Developmental & Stem Cell Biology and Division of Neurosurgery, Hospital for Sick Children, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Ataxia-telangiectasia mutated

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Cisplatin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A